Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

Abroad (travel likely)Recruiting

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama, Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Kathryn Zamora, MD) · qmooney@uabmc.edu
Boca Raton Regional Hospital - Christine E. Lynn Women's Health and Wellness Institute, Boca Raton, Florida, United States
Contact: Study coordinator (Kathy Schilling, MD) · gabrielle.mcnall@BaptistHealth.net
Lake Medical Imaging, The Villages, Florida, United States
Boston Breast Diagnostic Center, Wellesley Hills, Massachusetts, United States
Contact: Study coordinator (Jordana Phillips, MD)
Henry Ford Health, Detroit, Michigan, United States
Contact: Study coordinator (Sabala Mandava, MD) · CCTROBreastTeam@hfhs.org
Thomas Jefferson University, Sewell, New Jersey, United States
Contact: Study coordinator (Karishma Kurowski, MD) · Karishma.Kurowski@jefferson.edu
Contact: Principal Investigator (Jason Shames, MD)
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Tali Amir, MD) · ziedenj@mskcc.org
Carolina Breast Imaging Specialists, Greenville, North Carolina, United States
Contact: Study coordinator (Bruce Schroeder,, MD) · schroeder@cbispecialists.com
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Jason Shames, MD) · Trang.Vu2@jefferson.edu
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Olena Weaver, MD) · BBBriones@mdanderson.org
University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Ramapriya Ganti, MD, PhD) · KLR3B@uvahealth.org
St. Joseph's Hospital, London, Ontario, Canada
Contact: Study coordinator (Anat Kornecki, MD) · deepanjali.kaushik@sjhc.london.on.ca

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Advanced Solid Tumor · Advanced Breast Cancer · Advanced Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Fullerton, United States

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Anchorage, United States

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

HER2-positive Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Bengbu, China · Fuyang, China